At Dekabi Clinic, stem cell therapy for mental health conditions like depression and anxiety is designed to address neurotransmitter imbalances at a cellular and regenerative level, offering a novel alternative to traditional medications. Unlike conventional antidepressants—which primarily modulate serotonin, dopamine, or norepinephrine through pharmaceutical agents—stem cell therapy aims to repair and regenerate damaged neural tissues, potentially restoring natural neurotransmitter production. Dr. Eun Young Baek and her team utilize mesenchymal stem cells (MSCs) or other specialized stem cells, which can differentiate into neural-supportive cells, release neurotrophic factors (e.g., BDNF), and reduce inflammation in the brain—key contributors to mood disorders. This approach not only targets symptom relief but also addresses underlying neurodegeneration or synaptic dysfunction, which many traditional drugs do not fully reverse. Additionally, stem cell therapy may reduce reliance on medications with side effects like emotional blunting or dependency, though individual responses vary. Dekabi Clinic emphasizes personalized protocols, combining stem cell treatments with diagnostic tools to assess neurobiological improvements over time.
For deeper insights: Dekabi Clinic’s Approach.